Preventing Postpartum Hemorrhage from Research to Practice Workshop Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
South Asia Conference for the Prevention & Treatment of Obstetric
CH_6460 FC_BC 8/4/04 2:02 PM Page 3 south asia conference for the prevention & treatment of obstetric fistula 9-11 december 2003 • dhaka, bangladesh CH_6460 Text 8/4/04 2:12 PM Page 1 south asia conference for the prevention & treatment of obstetric fistula 9-11 december 2003 • dhaka, bangladesh CH_6460 Text 8/4/04 2:12 PM Page 2 Dr. Sayeba Akhter, Professor and the Head of Gynaecology & Obstetrics Department of the Dhaka Medical College Hospital, with two of her patients awaiting repair in the fistula ward of the hospital. cover: Esmithi, 22 years old, struggled for three days at home without a doctor or midwife trying to give birth to her son. Unlike most other fistula patients, Esmithi’s baby was born alive and healthy, but the strain of the labour left her leaking urine. She lived with the condition for one year before she and her husband learned that treatment was available at the Dhaka Medical Hospital in Bangladesh. Photo by Mari Tikkanen/UNFPA CH_6460 Text 8/4/04 2:12 PM Page 3 contents acknowledgements 2 foreword 3 conference recommendations 4 highlights of the discussions 7 background on obstetric fistula and 8 the global campaign statement by dr. nafis sadik 10 country presentations 11 south asia: regional overview 11 bangladesh: situation analysis 13 nepal: reproductive health morbidity survey 15 india: preliminary surveys 16 pakistan: fistula repair camps 17 annex 1: agenda 18 annex 2: list of participants 19 annex 2: participants from bangladesh 20 CH_6460 Text 8/4/04 2:12 PM Page 4 acknowledgements This meeting could not have been successful without the efforts of all who have worked tirelessly, to make sure that the world does not forget that women continue to suffer from fistula. -
Fistula Annual Report-2019-15-07-2020-02
Annual Report on Obstetric Fistula in Bangladesh Progress and Highlights 2019 Annual Report on Obstetric Fistula in Bangladesh Progress and Highlights 2019 Annual Report on Obstetric Fistula in Bangladesh Progress and Highlights 2019 Editorial Board Prof. Dr Nasima Sultana, Additional Director-General, DGHS Dr Md. Shamsul Haque, Line Director, MNC&AH, DGHS Dr Md. Azizul Alim, Program Manager, MNH, DGHS Prof. Dr Sameena Chowdhury, President, OGSB Prof. Dr Anowara Begum, Past President, OGSB and Chairman, OGSB Sub Committee Prof. Dr Sayeba Akhter, Past President, OGSB and President, ISOFS (Elect.) Prof. Dr Saleha Bequm Chowdhury, Secretary General, OGSB Prof. Dr MA Halim, Director, CIPRB Dr Dewan Md. Emdadul Hoque, Health Systems Specialist, UNFPA Md Shamuz Zaman, Programme Analyst, UNFPA Dr Animesh Biswas, Technical Officer, Fistula and MPDSR, UNFPA Cover Photo Dr Animesh Biswas Published By Maternal Health Program Directorate General of Health Services Government of the People's Republic of Bangladesh Published January 2020 Content Abbreviations 10 Executive Summery 11 Introduction 12 Capacity Development 13 Fistula Identification 16 Fistula Diagnosis, Referral and Management 19 Fistula Rehabilitation and Reintegration 23 Advocacy, Development and Planning 25 Highlights 28 Message Obstetric fistula is a debilitating condition that affects a total of one million women globally. In Bangladesh, recent survey results show that around 20,000 women are suffering from obstetric fistula currently, and another 1000 cases are adding every year. The trend of the iatrogenic fistula is increasing now a day in comparison to obstetric fistula in Bangladesh. DGHS through the Ministry of Health and family welfare has launched the 2nd national strategy to end obstetric fistula highlighted to End Obstetric Fistula from Bangladesh by 2030. -
Strategic Assessment of Usaid Bangladesh Fistula Program
STRATEGIC ASSESSMENT OF USAID BANGLADESH FISTULA PROGRAM April 2019 This publication was produced at the request of the United States Agency for International Development. It was prepared independently by Karen Beattie, M.A., Steven Arrowsmith, M.D., Alexandre Delamou, M.D., Ph.D., and Nadira Sultana MBBS, MSc. Cover Photo: Former fistula patients who participate in Ad-din Jessore’s micro-finance program. From left to right: Rakha, Hosnara, Jinnatunnasa, Rathna, Farida, and Ayasha. Credit: Karen Beattie. STRATEGIC ASSESSMENT OF USAID BANGLADESH FISTULA PROGRAM April 2019 USAID Contract No. AID-OAA-C-14-00067; Assessment Assignment Number: 644 DISCLAIMER The authors’ views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government. This document is available online at the GH Pro website at http://ghpro.dexisonline.com/reports- publications. Documents are also made available through the Development Experience Clearinghouse (http://dec.usaid.gov). Additional information is available from: Global Health Program Cycle Improvement Project 1331 Pennsylvania Avenue NW, Suite 300 Washington, D.C. 20006 Phone: (1-202) 625-9444 Fax: (1-202) 517-9181 http://ghpro.dexisonline.com/reports-publications This document was submitted by GH Pro to the United States Agency for International Development under USAID Contract No. AID-OAA-C-14-00067. ABSTRACT The Fistula Care Plus (FC+) project is a five-year global project supported by the USAID Offices of Population and Reproductive Health and Maternal and Child Health and Nutrition. The project began in 2013 and was recently extended to March 2021.1 The project is designed to prevent, detect, and treat obstetric fistula (OF), an abnormal connection between the genital tract and bladder, resulting in a continuous flow of urine and/or feces after prolonged obstructed labor during childbirth, normally occurring where women do not have access to emergency obstetric care. -
A Framework for Analyzing the Determinants of Obstetric Fistula Formation
A Framework for Analyzing the Determinants of Obstetric Fistula Formation L. Lewis Wall Obstetric fistula, a devastating complication of prolonged obstructed labor, was once common in the Western world but now occurs almost exclusively in resource-poor countries. Although much has been written about the surgical repair of obstetric fistulas, prevention of fistulas has garnered comparatively little attention. Because obstetric fistulas result from obstructed labor (one of the common causes of maternal death in impoverished countries), this study assesses the obstetric fistula problem using a framework originally developed to analyze the determinants of maternal mortality. The framework identifies and explicates three sets of determinants of obstetric fistulas: the general socioeconomic milieu in which such injuries occur (the status of women, their families, and their communities); intermediate factors (health, reproductive status, and use of health care resources); and the acute clinical factors that determine the ultimate outcome of any particular case of obstructed labor. Interventions most likely to work rapidly in fistula prevention are those that have a direct impact on acute clinical situations, but these interventions will only be effective when general socioeconomic and cultural conditions promote an enabling environment for health care delivery and use. Sustained efforts that impact all three levels of determining factors will be necessary to eradicate obstetric fistula. (STUDIE S IN FAMILY PLANNING 2012; 43[4]: 255–272) Obstetric fistula is a devastating childbirth injury preva- woman completely incontinent of urine, feces, or both. lent in resource-poor countries that have high maternal Fistulas rarely heal without surgery, and because access mortality rates. Fistulas are caused by prolonged labor in to surgical services is poor in those parts of the world which the fetus cannot fit through the mother’s birth ca- where maternal mortality and obstetric fistulas are com- nal. -
Fistula Care Plus Associate Cooperative Agreement AID-OAA-A14-00013 Annual Report October 1, 2017 to September 30, 2018
Fistula Care Plus Associate Cooperative Agreement AID-OAA-A14-00013 Annual Report October 1, 2017 to September 30, 2018 Managing Partner: EngenderHealth; Associate Partners: The Population Council, Dimagi, Direct Relief, Fistula Foundation, Maternal Health Task Force, TERREWODE Submitted to United States Agency for International Development Washington, D.C. November 30, 2018 EngenderHealth 505 9th St. NW, Suite 601 Washington, DC 20004 Telephone: (202) 902 2000 Fax: (202) 783 0281 E-mail: [email protected] Copyright 2018. EngenderHealth/Fistula Care Plus. All rights reserved. Fistula Care Plus (FC+) c/o EngenderHealth 505 9th St. NW, Suite 601 Washington, DC 20004 Telephone: (202) 902 2000 Fax: (202) 783 0281 E-mail:[email protected] www.fistulacare.org This publication is made possible by the generous support of the American people through the Office of Maternal and Child Health, U.S. Agency for International Development (USAID), under the terms of cooperative agreement AID-OAA-A14-00013. The contents are the responsibility of the Fistula Care Plus project and do not necessarily reflect the views of USAID or the United States Government. TABLE OF CONTENTS TABLE OF CONTENTS ........................................................................................................................... 2 ACRONYMS AND ABBREVIATIONS ................................................................................................... 5 TABLES ...................................................................................................................................................... -
Fistula Care Plus Associate Cooperative Agreement AID-OAA-A14-00013 Annual Report October 1, 2016 to September 30, 2017
Fistula Care Plus Associate Cooperative Agreement AID-OAA-A14-00013 Annual Report October 1, 2016 to September 30, 2017 Managing Partner: EngenderHealth; Associate Partners: The Population Council, Dimagi, Direct Relief, Fistula Foundation, Maternal Health Task Force, TERREWODE Submitted to United States Agency for International Development Washington, D.C. November 30, 2017 EngenderHealth 440 Ninth Avenue, New York, NY 10001, USA Telephone: 212-561-8000 Fax: 212-561-8067 E-mail: [email protected] Copyright 2017. EngenderHealth/Fistula Care Plus. All rights reserved. Fistula Care Plus (FC+) c/o EngenderHealth 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 E-mail:[email protected] www.fistulacare.org This publication is made possible by the generous support of the American people through the Office of Maternal and Child Health, U.S. Agency for International Development (USAID), under the terms of cooperative agreement AID-OAA-A14-00013. The contents are the responsibility of the Fistula Care Plus project and do not necessarily reflect the views of USAID or the United States Government. TABLE OF CONTENTS TABLE OF CONTENTS ........................................................................................................................... 2 ACRONYMS AND ABBREVIATIONS ................................................................................................... 4 TABLES ...................................................................................................................................................... -
Fistula Care Associate Cooperative Agreement GHS-A-00-07-00021-00
Fistula Care Associate Cooperative Agreement GHS-A-00-07-00021-00 Final Project Report October 2007 to December 2013 Part 1I: Country Accomplishments Submitted to United States Agency for International Development Washington, DC February 5, 2014 Copyright 2014. EngenderHealth/Fistula Care. All rights reserved. Fistula Care c/o EngenderHealth 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 email:[email protected] www.fistulacare.org This publication is made possible by the generous support of the American people through the Office of Maternal and Child Health, U.S. Agency for International Development (USAID), under the terms of associate cooperative agreement GHS-A-00-07-00021-00. The contents are the responsibility of the Fistula Care project and do not necessarily reflect the views of USAID or the United States Government. Printed in the United States of America. Printed on recycled paper. CONTENTS, Part II ACRONYMS AND ABBREVIATIONS ........................................................................................................ V INTRODUCTION ........................................................................................................................................ 1 BANGLADESH ............................................................................................................................................. 3 DEMOCRATIC REPUBLIC OF THE CONGO (DRC) ............................................................................. 15 ETHIOPIA ..................................................................................................................................................